Detection, clinical relevance and specific biological properties of disseminating tumour cells

K Pantel, RH Brakenhoff, B Brandt - Nature Reviews Cancer, 2008 - nature.com
Most cancer deaths are caused by haematogenous metastatic spread and subsequent
growth of tumour cells at distant organs. Disseminating tumour cells present in the …

Circulating tumor cells (CTC) detection: clinical impact and future directions

P Paterlini-Brechot, NL Benali - Cancer letters, 2007 - Elsevier
Recent molecular and clinical studies have shown that invasion may occur very early in
tumor development, thus emphasizing the potential importance of specific and sensitive …

Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics

ME Warkiani, BL Khoo, L Wu, AKP Tay, AAS Bhagat… - Nature protocols, 2016 - nature.com
Circulating tumor cells (CTCs) are rare cancer cells that are shed from primary or metastatic
tumors into the peripheral blood circulation. Phenotypic and genetic characterization of …

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

WJ Allard, J Matera, MC Miller, M Repollet… - Clinical cancer …, 2004 - AACR
Purpose: The purpose of this study was to determine the accuracy, precision, and linearity of
the CellSearch system and evaluate the number of circulating tumor cells (CTCs) per 7.5 mL …

Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device

BL Khoo, G Grenci, YB Lim, SC Lee, J Han, CT Lim - Nature protocols, 2018 - nature.com
The development of personalized cancer therapy depends on a robust system to monitor the
patient's individual response to anticancer treatment. Anticancer drug efficacy has been …

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity

V Müller, N Stahmann, S Riethdorf, T Rau… - Clinical Cancer …, 2005 - AACR
Purpose: The incidence and biological characteristics of circulating tumor cells in the blood
of patients with breast cancer were examined and subgroups were evaluated in the context …

Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival

IH Benoy, R Salgado, P Van Dam, K Geboers… - Clinical Cancer …, 2004 - AACR
Purpose: The prognostic significance of serum interleukin (IL)-8 was evaluated in patients
with metastatic breast cancer. The predictive value of serum IL-8 for the presence of occult …

Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells

SA Joosse, J Hannemann, J Spötter, A Bauche… - Clinical Cancer …, 2012 - AACR
Purpose: Circulating tumor cells (CTC) might function as early markers for breast cancer
metastasis or monitoring therapy efficacy. Enrichment and identification of CTCs are based …

Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse—a European pooled analysis

W Janni, FD Vogl, G Wiedswang, M Synnestvedt… - Clinical Cancer …, 2011 - AACR
Background: The prognostic significance of disseminated tumor cells (DTC) in bone marrow
(BM) of breast cancer patients at the time of primary diagnosis has been confirmed by a …

Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood

R Rosenberg, R Gertler, J Friederichs… - … : The Journal of the …, 2002 - Wiley Online Library
Background The detection of disseminated tumor cells in peripheral blood is limited by the
presence of very few tumor cells within a large number of blood cells. Therefore, tumor cell …